Whether you’re traveling near or far, for work or for pleasure, worrying about your eye health shouldn’t get in the way. Eye conditions, including keratoconus, shouldn’t prevent you from living your life and enjoying what you love. So, book the ticket, mark your calendar, and pack your bags!
If your doctor has recommended iLink FDA-approved corneal cross-linking— the first and only FDA-approved therapeutic treatment that stiffens the cornea to slow or halt the progression of keratoconus, then you may now be eligible to receive up to $100 towards your non-reimbursable copay expenses through our new patient support program.
For over 40 years, Jimmy learned to live with and manage his progressive keratoconus using a contact lens. At the time, this was the only available treatment option for keratoconus aside from a corneal transplant. However, his contact lens was only treating the symptoms of his keratoconus, and not the underlying cause. As his keratoconus continued to progress and negatively impact his life, potentially needing corneal transplant became a concern.
If untreated, keratoconus may result in significant vision loss and can lead to a corneal transplant in severe cases. However, there are various FDA-approved treatment options available that work to treat the symptoms caused by the thinning and bulging of the cornea.
A corneal transplant may be the only option when the cornea becomes dangerously thin or when sufficient vision can no longer be achieved by contact lenses due to corneal steepening, scarring, or lens intolerance. We’ve compiled some information for you, including an overview of the connection between keratoconus and corneal donations, organ donations, organizations you should be aware of, and how to become a donor. Keep reading to learn more.
Whether you were recently diagnosed with keratoconus, or have been living with it for years, you may be wondering more about this lesser-known – and often misdiagnosed – eye condition. If you’re not familiar, keratoconus, often referred to as KC, is an eye condition in which the cornea weakens and thins over time, causing the development of a cone-like bulge and optical irregularity of the cornea. The condition may result in significant vision loss and can require a corneal transplant in severe cases.
Headaches and light sensitivity are two common conditions that you most likely have heard of before or experienced firsthand. Although there are some easy fixes for these uncomfortable and sometimes inconvenient conditions, it can be stressful if they continue to occur without a known or obvious explanation. While these two bothersome ailments can be caused by a number of different factors, they may be the result of an underlying vision issue, such as keratoconus.
For people diagnosed with progressive keratoconus, it’s likely that iLink FDA-approved cross-linking will be recommended to halt or slow the progression of the condition. Whether your cross-linking procedure is scheduled or you’ve been considering it for a while now, you may be interested in learning more about this minimally invasive procedure.
iLink FDA-approved cross-linking is the only treatment option proven safe and effective in slowing or halting the progression of keratoconus to help preserve patients’ vision.
In June 2019, fourteen years after receiving Lasik to fix her vision, Trayci, 51, noticed her eyesight was declining again. Soon after, she was diagnosed with progressive keratoconus, a rare eye disease in which the cornea weakens and thins over time, causing a cone-like bulge and optical irregularity.
